Oxford Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,684
| Closed | -$801K | – | 982 |
|
|
2019
Q4 | $801K | Sell |
17,684
-19,993
| -53% | -$906K | 0.02% | 990 |
|
|
2019
Q3 | $1.43M | Buy |
37,677
+6,165
| +20% | +$235K | 0.03% | 736 |
|
|
2019
Q2 | $1.37M | Buy |
31,512
+4,261
| +16% | +$185K | 0.03% | 822 |
|
|
2019
Q1 | $1.04M | Sell |
27,251
-27,255
| -50% | -$1.04M | 0.02% | 910 |
|
|
2018
Q4 | $2.35M | Buy |
54,506
+19,085
| +54% | +$821K | 0.06% | 387 |
|
|
2018
Q3 | $1.74M | Sell |
35,421
-14,503
| -29% | -$712K | 0.04% | 741 |
|
|
2018
Q2 | $1.55M | Buy |
49,924
+32,271
| +183% | +$1M | 0.03% | 812 |
|
|
2018
Q1 | $550K | Sell |
17,653
-81,212
| -82% | -$2.53M | 0.01% | 1201 |
|
|
2017
Q4 | $4.49M | Buy |
98,865
+33,624
| +52% | +$1.53M | 0.1% | 252 |
|
|
2017
Q3 | $2.53M | Buy |
65,241
+3,933
| +6% | +$152K | 0.05% | 503 |
|
|
2017
Q2 | $2.92M | Buy |
61,308
+44,610
| +267% | +$2.13M | 0.06% | 414 |
|
|
2017
Q1 | $761K | Buy |
+16,698
| New | +$761K | 0.02% | 912 |
|
|
2016
Q3 | – | Sell |
-29,061
| Closed | -$980K | – | 832 |
|
|
2016
Q2 | $980K | Buy |
+29,061
| New | +$980K | 0.03% | 489 |
|
|
2016
Q1 | – | Sell |
-170,199
| Closed | -$13.2M | – | 868 |
|
|
2015
Q4 | $13.2M | Buy |
170,199
+141,695
| +497% | +$11M | 0.31% | 54 |
|
|
2015
Q3 | $1.17M | Sell |
28,504
-275
| -1% | -$11.3K | 0.04% | 381 |
|
|
2015
Q2 | $2.04M | Sell |
28,779
-68,112
| -70% | -$4.82M | 0.06% | 342 |
|
|
2015
Q1 | $8.61M | Sell |
96,891
-26,408
| -21% | -$2.35M | 0.22% | 100 |
|
|
2014
Q4 | $11.1M | Sell |
123,299
-32,014
| -21% | -$2.88M | 0.24% | 67 |
|
|
2014
Q3 | $15.4M | Buy |
155,313
+7,889
| +5% | +$782K | 0.35% | 45 |
|
|
2014
Q2 | $13.5M | Buy |
+147,424
| New | +$13.5M | 0.44% | 38 |
|
|
2013
Q4 | – | Sell |
-46,071
| Closed | -$2.22M | – | 767 |
|
|
2013
Q3 | $2.22M | Sell |
46,071
-80,051
| -63% | -$3.85M | 0.05% | 428 |
|
|
2013
Q2 | $3.66M | Buy |
+126,122
| New | +$3.66M | 0.1% | 337 |
|